Kaitlin Rainwater-Lovett
Overview
Explore the profile of Kaitlin Rainwater-Lovett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
796
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leone R, Rainwater-Lovett K, Hanfling D
Disaster Med Public Health Prep
. 2025 Feb;
19:e32.
PMID: 39949205
The convergence of medical and technological developments has continued to transform the delivery of medical care in disaster environments, incorporating advances from telecommunications to physiologic monitoring, artificial intelligence, and computer...
2.
Lopez V, Cramer E, Pagano R, Drake J, ODea E, Adee M, et al.
PLoS Comput Biol
. 2024 May;
20(5):e1011200.
PMID: 38709852
During the COVID-19 pandemic, forecasting COVID-19 trends to support planning and response was a priority for scientists and decision makers alike. In the United States, COVID-19 forecasting was coordinated by...
3.
Howerton E, Contamin L, Mullany L, Qin M, Reich N, Bents S, et al.
Nat Commun
. 2023 Nov;
14(1):7260.
PMID: 37985664
Our ability to forecast epidemics far into the future is constrained by the many complexities of disease systems. Realistic longer-term projections may, however, be possible under well-defined scenarios that specify...
4.
Panaggio M, Wilson S, Ratcliff J, Mullany L, Freeman J, Rainwater-Lovett K
Health Secur
. 2023 Sep;
21(S1):S79-S88.
PMID: 37756211
No abstract available.
5.
Howerton E, Contamin L, Mullany L, Qin M, Reich N, Bents S, et al.
medRxiv
. 2023 Jul;
PMID: 37461674
Our ability to forecast epidemics more than a few weeks into the future is constrained by the complexity of disease systems, our limited ability to measure the current state of...
6.
Truelove S, Smith C, Qin M, Mullany L, Borchering R, Lessler J, et al.
Elife
. 2022 Jun;
11.
PMID: 35726851
In Spring 2021, the highly transmissible SARS-CoV-2 Delta variant began to cause increases in cases, hospitalizations, and deaths in parts of the United States. At the time, with slowed vaccination...
7.
Panaggio M, Rainwater-Lovett K, Nicholas P, Fang M, Bang H, Freeman J, et al.
Epidemics
. 2022 May;
39:100580.
PMID: 35636313
During the COVID-19 pandemic, concerns about hospital capacity in the United States led to a demand for models that forecast COVID-19 hospital admissions. These short-term forecasts were needed to support...
8.
Cramer E, Ray E, Lopez V, Bracher J, Brennen A, Castro Rivadeneira A, et al.
Proc Natl Acad Sci U S A
. 2022 Apr;
119(15):e2113561119.
PMID: 35394862
Short-term probabilistic forecasts of the trajectory of the COVID-19 pandemic in the United States have served as a visible and important communication channel between the scientific modeling community and both...
9.
Caglayan C, Thornhill J, Stewart M, Lambrou A, Richardson D, Rainwater-Lovett K, et al.
Front Public Health
. 2022 Feb;
9:770039.
PMID: 35155339
Background: The COVID-19 pandemic has significantly stressed healthcare systems. The addition of monoclonal antibody (mAb) infusions, which prevent severe disease and reduce hospitalizations, to the repertoire of COVID-19 countermeasures offers...
10.
Lambrou A, Redd J, Stewart M, Rainwater-Lovett K, Thornhill J, Hayes L, et al.
Disaster Med Public Health Prep
. 2022 Jan;
17:e112.
PMID: 35027098
Monoclonal antibody therapeutics to treat coronavirus disease (COVID-19) have been authorized by the US Food and Drug Administration under Emergency Use Authorization (EUA). Many barriers exist when deploying a novel...